New heart pump device aims to support patients during risky procedures

NCT ID NCT06565039

Terminated Disease control Sponsor: Supira Medical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study was designed to test the safety and effectiveness of the Supira System, a temporary heart pump, in patients undergoing high-risk coronary interventions. The device is inserted through a leg artery to help pump blood from the heart to the body during the procedure. However, the trial was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Supira System (temporary heart pump device)

What this could lead to

If successful, this device could provide a safer way to support the heart during high-risk procedures, potentially reducing complications.

What could go wrong

This trial was withdrawn before enrolling any participants, so no data is available. The device is still early in testing, and its safety and effectiveness are unproven.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR ASSIST DEVICE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disease, severe, susceptibility to coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTRICULAR ASSIST DEVICE